Leyla Raiani
May 1, 2012

Green nanotechnology could enhance medication delivery

Researchers at McLean Hospital have shown a new category of "green" nanoparticles, non-toxic, protein-based particles that can non-invasively cross the blood brain barrier and are capable of transporting various types of drugs.The study reported that clathrin protein, a ubiquitous protein found in human, animal, plant, bacteria and fungi cells, can been modified for use as a nanoparticle. Clathrin is the body's primary delivery vehicle responsible for delivering many different types of molecules into cells. This new study provides a fresh insight into utilizing bioengineered clathrin protein as a novel nanoplatform that passes the blood brain barrier. The researchers were able to show that the clathrin nanoparticles could be non-invasively delivered to the central nervous system in animals.

Companies
1
Patents
1
0 Comments
Related Articles
Jeff Herman
Apr 17, 2012
Nanobubbles and nanoparticles improve chemotherapy
Recently, in several articles here on Patexia, we have commented on the importance of nanotechnology in medicine, including everything from... Read More
Ada Genavia
Apr 18, 2012
Study finds evidence that nanoparticles may increase plant DNA damage
Researchers at the National Institute of Standards and Technology (NIST) and the University of Massachusetts Amherst (UMass) have provided the... Read More
Daniel Porter
Apr 25, 2012
Nanotechnology and Drug Delivery
Drug delivery is among the most significant obstacles facing modern medicine: the more we manufacture drugs to treat specific unhealthy... Read More